| 4:00–8:00 PM | Registration |
| 6:00–8:00 PM | Welcome Mixer |
| 7:00–8:00 AM | Breakfast |
| 8:00–9:00 AM | Welcome and Keynote Address |
| Dianne K. Newman, California Institute of Technology Rethinking AMR: How Heterogeneity in Metabolism Shapes Drug Resistance |
| 9:00–11:15 AM | Phage Biology and Therapy: Basic |
| Andrew Camilli, Tufts University Phage Cocktails for the Control of Cholera |
| Katrine L. Whiteson, University of California, Irvine Experimental Evolution of Gram Positive-Targeting Phages |
| Martha Clokie, University of Leicester Getting Bacteriophages Closer to Clinical Development |
| Short Talk(s) Chosen from Abstracts |
| 9:30–9:50 AM | Coffee Break |
| 11:15–1:00 PM | Poster Setup |
| 11:15–5:00 PM | On Own for Lunch |
| 1:00–10:00 PM | Poster Viewing |
| 2:30–4:30 PM | Symposia Spotlight 1: Late-breaking research presentations selected from abstract submissions |
| Short Talks Chosen from Abstracts |
| 4:30–5:00 PM | Coffee Available |
| 5:00–7:00 PM | Phage Biology and Therapy: Applied |
| Daria Van Tyne, University of Pittsburgh Functional Genomics and Phage Therapy for Antibiotic-Resistant Bacterial Infections |
| Paul E. Turner, Yale University Leveraging Evolution to Fight Antibiotic Resistance with Phage Therapy |
| Susan M. Lehman, U.S. Food and Drug Administration An in vitro Preclinical Model of Phage Dosing for Localized Infections |
| Jennifer A. Schwartz †, INTRALYTIX, INC. Phage Control of Pathogens in Food Processing, Medicine, and Environmental Settings |
| Short Talk(s) Chosen from Abstracts |
| 7:00–8:00 PM | Social Hour with Dinner |
| 7:30–10:00 PM | Poster Session 1 |
| 7:00–8:00 AM | Breakfast |
| 8:00–11:00 AM | Harnessing the Microbiome for Infection: Basic |
| Mariana X. Byndloss, Vanderbilt University Medical Center Host-Microbiota Metabolic Interactions during Infectious Gastroenteritis |
| Vanessa Sperandio, University of Wisconsin Microbiota Control of EHEC Pathogenesis |
| Bärbel Stecher, TUM School of Life Sciences Using Defined Microbiota Communities to Reveal Novel Insights into Colonization Resistance Against Salmonella |
| Short Talk(s) Chosen from Abstracts |
| 9:00–9:20 AM | Coffee Break |
| 11:00–1:00 PM | Poster Setup |
| 11:00–5:00 PM | On Own for Lunch |
| 1:00–10:00 PM | Poster Viewing |
| 3:00–4:30 PM | Career Roundtable |
| 4:30–5:00 PM | Coffee Available |
| 5:00–7:00 PM | Harnessing the Microbiome for Infection: Applied |
| Joseph P. Zackular, University of Pennsylvania Leveraging Ecology to Design New Therapeutic Strategies Against Clostridioides Difficile |
| Julie A. Segre, National Institutes of Health Human Skin Microbiome: From Friends to Foes |
| Greg Medlock, Vedanta Biosciences Microbiome Therapeutics in the Age of Multi-Drug Resistant Pathogens |
| Short Talk(s) Chosen from Abstracts |
| 7:00–8:00 PM | Social Hour with Dinner |
| 7:30–10:00 PM | Poster Session 2 |
| 7:00–8:00 AM | Breakfast |
| 8:00–11:00 AM | Leveraging Immunity to Combat Bacterial Infection: Basic |
| Kimberly Kline, University of Geneva Host-Pathogen Interactions in Mixed-Species Infections |
| Victor Torres, St. Jude Children's Research Hospital Impact of Nutrition on Host-Pathogen Interactions during ESKAPE Pathogen Infection |
| Raphael Valdivia, Duke University Akkermansia Mediated Control of Mucosal Immunity |
| Short Talk(s) Chosen from Abstracts |
| 9:00–9:20 AM | Coffee Break |
| 11:00–5:00 PM | On Own for Lunch |
| 2:30–4:30 PM | Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions |
| Short Talks Chosen from Abstracts |
| 4:30–5:00 PM | Coffee Available |
| 5:00–7:00 PM | Leveraging Immunity to Combat Bacterial Infection: Applied |
| Molly A Ingersoll, Institut Cochin & Institut Pasteur Leveraging Mucosal Immunity in the Fight Against Recurrent Urinary Tract Infection |
| Man-Wah Tan, Genentech, Inc. Developing the Next-Generation of Therapeutics for Bacterial Infection |
| Andreas Peschel, Interfaculty Institute of Microbiology and Infection Medicine Teichoic Acids at the Staphylococcus-Host Interface |
| Ann Marie Stanley, AstraZeneca Monoclonal Antibodies to Prevent and Treat Bacterial Infections |
| Short Talk(s) Chosen from Abstracts |
| 7:00–7:15 PM | Meeting Wrap-Up: Outcomes and Future Directions (Organizers) |
| 7:15–8:15 PM | Social Hour with Dinner |
| 8:00–11:00 PM | Cash Bar |
| 8:00–11:00 PM | Entertainment |
| 12:00–11:59 PM | Departure |